derinet® Switzerland
Product names from:
VontobelSVSP
Back

16.00% (14.96% p.a.) Defender VONTI on Teva Pharmaceutical Industries Ltd.

  • Valor 50613307
  • ISIN CH0506133070
  • Symbol RTEADV
Bid (indicative)%
Ask (indicative)%
CurrencyUSD
Price on
Sell
Buy
Teva Pharmaceutical Industries Ltd.USD 
Please note that this is an indication.

Documents

Interest
Coupon (Coupon p.a.)16.00% (14.96%)
Accrued interest3.86%
Premium component13.9646%
Interest share2.0354%
Day count convention30/360
Pricingclean
Life cycle
Initial fixing20/12/2019
Payment date30/12/2019
Last trading day15/01/2021
Final fixing15/01/2021
Redemption25/01/2021

Current price information

Intraday1 week1 monthyear to dateSince emission
until
Product Underlying

Loading data

Performance
UnderlyingClosing PriceStrike PriceBarrierBuffer
USD 8.40USD 10.12USD 5.06

No chart available

Interest
Coupon (Coupon p.a.)16.00% (14.96%)
Accrued interest3.86%
Premium component13.9646%
Interest share2.0354%
Day count convention30/360
Pricingclean
Life cycle
Initial fixing20/12/2019
Payment date30/12/2019
Last trading day15/01/2021
Final fixing15/01/2021
Redemption25/01/2021
Figures
Product typeDefender VONTI
SSPA categorisationBarriere Reverse Convertible
Issue price100.00%
Nominal valueUSD 1,000.00
Reference currencyUSD
QuantoNo
Strike price

Reference price of the underlying used to calculate the cash settlement on expiry of the warrant. In cases of physical delivery it is the price at which the underlying is bought (call) or sold (put). Also called: exercise price

USD 10.12
BarrierUSD 5.06 (50.00%)
Barrier observationcontinuous
Underlying/
ISIN of underlying
Teva
US8816242098
Spot reference priceUSD 10.12
COSINo
ListingSIX Structured Products Exchange
Additional conditions
IssuerVontobel Financial Products Ltd., DIFC Dubai
GuarantorVontobel Holding AG, Zurich
Lead ManagerBank Vontobel AG, Zurich
Redemption / deliverycash payment
Issuance ProgrammeLink to the Issuance Program